Breast Cancer :: 4 genes identified spreading breast cancer
Studies of human tumor cells implanted in mice have shown that the abnormal activation of four genes drives the spread of breast cancer to the lungs.
Studies of human tumor cells implanted in mice have shown that the abnormal activation of four genes drives the spread of breast cancer to the lungs.
Researchers at the University of Colorado at Denver and Health Sciences Center have found that nitric oxide plays an important role in tumor cell survival following treatment with radiation therapy.
A drug under study to treat various cancers selectively kills cancer cells because of its affinity for a modified version of a critical heat shock protein they contain, researchers have found.
By combining two techniques, magnetic resonance imaging (MRI) and near-infrared optics, researchers at Dartmouth College and Dartmouth Medical School may have devised a new, potentially more accurate method for diagnosing breast cancer.
A new study in Psychophysiology confirms a surprising fact ? men who have undergone chemical castration for conditions such as prostate cancer experience hot flashes similar to those experienced by menopausal women.
Gleevec, a pill developed in conjunction with Oregon Health & Science University is again showing excellent results in preventing cancer recurrence in GIST patients after complete removal of their tumors.
Among men who have received similar treatments for prostate cancer, those with less education ? particularly those who did not graduate from high school ? experience a significant drop in their quality of life after treatment compared with men who have more education, according to a study led by researchers at the San Francisco VA Medical Center (SFVAMC).
Although the ACS guidelines find screening MRIs of uncertain value for breast cancer survivors, a newly published study shows the scans can be useful for finding tumors in the opposite (contralateral) breast of women newly diagnosed with the disease.
Oncolytics Biotech Inc. (“Oncolytics”) (TSX:ONC, NASDAQ:ONCY) announced that subsequent to the regulatory review period for this submission, it is proceeding with a Phase II trial to evaluate the intravenous administration of REOLYSIN? in patients with various sarcomas that have metastasized to the lung.
Two health groups are joining forces to fund three promising lung cancer researchers. The LUNGevity Foundation and the American Cancer Society are contributing $370,000 to fund the first-ever LUNGevity Foundation and American Cancer Society Lung Cancer Postdoctoral Fellowships.